[go: up one dir, main page]

NO952824L - Sterile gelsammensetninger for sårbehandling - Google Patents

Sterile gelsammensetninger for sårbehandling

Info

Publication number
NO952824L
NO952824L NO952824A NO952824A NO952824L NO 952824 L NO952824 L NO 952824L NO 952824 A NO952824 A NO 952824A NO 952824 A NO952824 A NO 952824A NO 952824 L NO952824 L NO 952824L
Authority
NO
Norway
Prior art keywords
gel compositions
alginate
aqueous gel
wound treatment
compositions
Prior art date
Application number
NO952824A
Other languages
English (en)
Norwegian (no)
Other versions
NO952824D0 (no
Inventor
Craig Julian Hardy
Charlotte Maria Findlay
Original Assignee
Johnson & Johnson Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical filed Critical Johnson & Johnson Medical
Publication of NO952824D0 publication Critical patent/NO952824D0/no
Publication of NO952824L publication Critical patent/NO952824L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A61L2/06—Hot gas
    • A61L2/07—Steam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0071—Plasticisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
NO952824A 1994-07-18 1995-07-17 Sterile gelsammensetninger for sårbehandling NO952824L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9414454A GB2291348B (en) 1994-07-18 1994-07-18 Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol

Publications (2)

Publication Number Publication Date
NO952824D0 NO952824D0 (no) 1995-07-17
NO952824L true NO952824L (no) 1996-01-19

Family

ID=10758502

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952824A NO952824L (no) 1994-07-18 1995-07-17 Sterile gelsammensetninger for sårbehandling

Country Status (14)

Country Link
US (1) US5693624A (pt)
EP (1) EP0693292B1 (pt)
JP (1) JPH08187280A (pt)
KR (1) KR960003732A (pt)
AT (1) ATE209510T1 (pt)
AU (1) AU696405B2 (pt)
BR (1) BR9503349A (pt)
CA (1) CA2153947A1 (pt)
DE (1) DE69524152T2 (pt)
FI (1) FI953453L (pt)
GB (1) GB2291348B (pt)
NO (1) NO952824L (pt)
TW (1) TW443932B (pt)
ZA (1) ZA955607B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9701552D0 (en) * 1997-01-25 1997-03-12 Bristol Myers Squibb Co Multi-dose wound gel
US6605751B1 (en) 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
GB2344519B (en) * 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
US6197061B1 (en) 1999-03-01 2001-03-06 Koichi Masuda In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage
US6046160A (en) * 1999-07-22 2000-04-04 Deroyal Industries, Inc. Composition and method for enhancing wound healing
ATE327779T1 (de) 1999-12-30 2006-06-15 Acrymed Methode und zusammensetzungen für verbesserte abgabevorrichtungen
FR2827764B1 (fr) * 2001-07-27 2005-08-19 Oreal Composition, notamment cosmetique, renfermant un steroide et un glycol
EP1435980A4 (en) * 2001-09-15 2006-06-07 Univ California LAMINATED CARTILAGINOUS FABRIC AND MANUFACTURING METHOD THEREOF
US20030165473A1 (en) * 2001-11-09 2003-09-04 Rush-Presbyterian-St. Luke's Medical Center Engineered intervertebral disc tissue
ES2251623T3 (es) * 2001-12-21 2006-05-01 Coloplast A/S Dispositivo de cuidado de heridas.
US20040001878A1 (en) * 2002-06-26 2004-01-01 Deroyal Industries, Inc. Infused wound care dressings
CN1678277B (zh) 2002-07-29 2010-05-05 艾克里麦德公司 治疗皮肤病的方法和组合物
US20050085749A1 (en) * 2003-10-15 2005-04-21 Kevin Baerwalde Device for therapeutic treatment of foot, heel, and/or like pain
US7745509B2 (en) 2003-12-05 2010-06-29 3M Innovative Properties Company Polymer compositions with bioactive agent, medical articles, and methods
KR20050086324A (ko) * 2004-02-25 2005-08-30 김아란 3%부터 9%까지 셀라인 (염수)
DE602005026225D1 (de) * 2004-03-12 2011-03-24 Cipla Ltd Sterilisationsprozess für Steroide
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
MX297476B (es) 2004-07-30 2012-03-26 Acrymed Inc Composiciones de plata antimicrobianas.
CN101010004B (zh) 2004-07-30 2012-10-03 金伯利-克拉克环球有限公司 抗微生物的装置和组合物
WO2006034249A2 (en) 2004-09-20 2006-03-30 Acrymed, Inc. Antimicrobial amorphous compositions
DE102006001954B4 (de) * 2006-01-16 2013-01-03 Lohmann & Rauscher Gmbh & Co. Kg Antiseptische Alginatzubereitung, Verfahren zu deren Herstellung, sowie deren Verwendung
EP2008663A4 (en) * 2006-03-22 2010-03-31 Cellgentech Inc LIQUID COMPOSITION FOR EXTERNAL ADMINISTRATION AND PREPARATION FOR EXTERNAL ADMINISTRATION FOR THE TREATMENT OF SKIN DISEASES
US8293965B2 (en) 2006-04-28 2012-10-23 Kimberly-Clark Worldwide, Inc. Antimicrobial site dressings
WO2009107189A1 (ja) 2008-02-25 2009-09-03 帝國製薬株式会社 ハイドロゲル創傷被覆材
US10232064B2 (en) 2006-10-04 2019-03-19 National Cheng Kung University Method for sterilizing biological materials
JP5661985B2 (ja) 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
US8283338B2 (en) * 2007-11-30 2012-10-09 Kao Corporation GIP secretion inhibitor
GB2460815A (en) 2008-04-04 2009-12-16 Kays Medical A sterilisable gel formulation comprising calcium gluconate
WO2010117266A1 (en) * 2009-04-06 2010-10-14 Broockeville Corporation N.V. In situ gelling alginate systems
EP2494953B1 (en) 2009-10-26 2017-09-27 Nissan Chemical Industries, Ltd. Composition for use as cosmetic or external skin preparation
WO2011112082A1 (en) 2010-03-11 2011-09-15 Bender Analytical Holding B.V. Sterile alginate-based aqueous composition for medical use and process for the preparation thereof
US9877871B2 (en) 2010-09-17 2018-01-30 Teikoku Seiyaku Co., Ltd. Method for using hydrogel sheet for treating wound
WO2011133064A1 (ru) * 2010-10-12 2011-10-27 Gavrilyuk Boris Karpovich Способ получения средства для устранения дефектов кожи и лечения ран в виде геля на основе водорастворимых полисахаридов растительного происхождения
RU2454242C1 (ru) * 2010-10-12 2012-06-27 Борис Карпович Гаврилюк Способ получения средства для устранения дефектов кожи и лечения ран в виде геля на основе водорастворимых полисахаридов растительного происхождения
EP2747760B1 (en) 2011-09-15 2015-07-15 Bender Analytical Holding B.V. Sterile alginate-based aqueous composition for medical use and process for the preparation thereof
MX2017004520A (es) 2014-10-14 2018-03-15 Lynch Samuel Composiciones para tratar heridas.
RU2616250C1 (ru) * 2015-12-01 2017-04-13 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ получения биоактивной сорбционно-гелиевой композиции
DE102019216424A1 (de) * 2019-10-24 2021-04-29 Mahle International Gmbh Ölkühlermodul

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640741A (en) * 1970-02-24 1972-02-08 Hollister Inc Composition containing gel
US4393048A (en) * 1980-02-15 1983-07-12 The United States Of America As Represented By The Secretary Of The Army Protective gel composition for wounds
US4391799A (en) * 1980-02-15 1983-07-05 The United States Of America As Represented By The Secretary Of The Army Protective gel composition for treating white phosphorus burn wounds
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
FR2489145A1 (fr) * 1980-09-04 1982-03-05 Geistlich Soehne Ag Compositions pharmaceutiques accelerant la guerison de blessures
EP0112852B1 (en) * 1982-06-24 1988-06-08 SMITH, Robert Alan Pharmaceutical gel composition
JPS5948413A (ja) * 1982-09-14 1984-03-19 Grelan Pharmaceut Co Ltd クリダナクを含有する消炎鎮痛外用剤
US4525348A (en) * 1983-12-19 1985-06-25 Yoshitomi Pharmaceutical Industries, Ltd. Pranoprofen gelled ointment
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
US5264422A (en) * 1986-06-30 1993-11-23 Fidia S.P.A. Esters of alginic acid with steroidal alcohols
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
DE3903672C1 (pt) * 1989-02-08 1990-02-01 Lohmann Gmbh & Co Kg
IT1248666B (it) * 1990-05-30 1995-01-26 Fidia Spa Gel in forma di film autosupportanti altamente idrati, processo per laloro preparazione e impiego nella terapia di lesioni e/o patologie cutanee
JP3254013B2 (ja) * 1991-09-10 2002-02-04 ジョンソン・アンド・ジョンソン・メディカル・インコーポレイテッド 包帯材料およびその製造方法
GB9209327D0 (en) * 1992-04-30 1992-06-17 Johnson & Johnson Medical Freeze-dried pad
GB9218749D0 (en) * 1992-09-04 1992-10-21 Courtaulds Plc Alginate gels
GB2276819B (en) * 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol

Also Published As

Publication number Publication date
ATE209510T1 (de) 2001-12-15
FI953453A7 (fi) 1996-01-19
GB2291348B (en) 1999-01-20
DE69524152T2 (de) 2002-05-16
DE69524152D1 (de) 2002-01-10
US5693624A (en) 1997-12-02
GB9414454D0 (en) 1994-09-07
FI953453L (fi) 1996-01-19
JPH08187280A (ja) 1996-07-23
EP0693292A1 (en) 1996-01-24
FI953453A0 (fi) 1995-07-17
BR9503349A (pt) 1996-02-27
TW443932B (en) 2001-07-01
GB2291348A (en) 1996-01-24
ZA955607B (en) 1997-01-06
AU696405B2 (en) 1998-09-10
NO952824D0 (no) 1995-07-17
EP0693292B1 (en) 2001-11-28
CA2153947A1 (en) 1996-01-19
KR960003732A (ko) 1996-02-23
AU2492895A (en) 1996-02-01

Similar Documents

Publication Publication Date Title
NO952824L (no) Sterile gelsammensetninger for sårbehandling
BG100910A (bg) Използване на бисфосфонати за инхибиране на костна резорбция след имплантиране на ортопедична протеза
FI955389A0 (fi) Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
HRP20060251A2 (en) Substituted oxasolidinones and their use
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
NO992400L (no) Nye substituerte pyrazolderivater
ES2123813T3 (es) Composiciones microbicidas para la desinfeccion de superficies inanimadas.
ES527494A0 (es) Procedimiento para esterilizar superficies que entraran en contacto con tejidos vivos
NZ544801A (en) Antiseptic compositions, methods and systems
ES2187719T3 (es) Derivados difluoroprostaglandinas y su aplicacion.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
EP0223681B1 (en) Alcohol-based antimicrobial compositions and method for enhancing their efficacity
BR9507730A (pt) Uso de formulações em gel como composições de tratamento
ATE220918T1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
NZ506681A (en) Disinfecting composition
BR0209846B1 (pt) utilizaÇço de um agente obtido pela irradiaÇço uv artificial de uma soluÇço aquosa para tratamento de esterilizaÇço de instrumentos mÉdicos.
DK0821593T3 (da) Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein
FI970715A0 (fi) Menetelmä luun parantamiseksi ja murtuman korjaamiseksi
AR005730A1 (es) Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato.
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica
ES2127036B1 (es) Aducto de norfloxacina soluble en agua.
SE9000300D0 (sv) Surgoerande komposition
EP0178928A3 (en) Vaccines
Gaw " A time to heal": The diffusion of Listerian doctrine in Victorian Britain.
Peltonen et al. Collagen and Bone Formation After Metaphyseal Osteotomy and Gradual Distraction

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application